Have all the ICD primary prevention trials excluded an important group of patients?

Islam Bolad, David T. Martin

Research output: Contribution to journalArticle

Abstract

Primary prevention trials of implantable cardioverter defibrillator (ICD) therapy have generally excluded patients early after revascularization. Clinicians are commonly faced with patients who have ventricular dysfunction and nonsustained ventricular tachyarrhythmia developing shortly after revascularization. Since there are no evidence-based guidelines, management is currently at the discretion of the treating clinician. Recently, evidence has emerged that this patient population is at increased risk of development of life-threatening ventricular tachyarrhythmia and, pending prospective trials, we suggest that ICD therapy should be used in appropriately selected patients with perioperative ventricular arrhythmia.

Original languageEnglish (US)
Pages (from-to)317-318
Number of pages2
JournalEuropace
Volume7
Issue number4
DOIs
StatePublished - Jul 2005
Externally publishedYes

Fingerprint

Implantable Defibrillators
Primary Prevention
Tachycardia
Ventricular Dysfunction
Cardiac Arrhythmias
Guidelines
Therapeutics
Population

Keywords

  • Cardiac surgery ventricular tachyarrhythmia
  • Implantable cardioverter defibrillator

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Have all the ICD primary prevention trials excluded an important group of patients? / Bolad, Islam; Martin, David T.

In: Europace, Vol. 7, No. 4, 07.2005, p. 317-318.

Research output: Contribution to journalArticle

@article{2b6395ad6f6f4c1aa101dc5f65db1e8e,
title = "Have all the ICD primary prevention trials excluded an important group of patients?",
abstract = "Primary prevention trials of implantable cardioverter defibrillator (ICD) therapy have generally excluded patients early after revascularization. Clinicians are commonly faced with patients who have ventricular dysfunction and nonsustained ventricular tachyarrhythmia developing shortly after revascularization. Since there are no evidence-based guidelines, management is currently at the discretion of the treating clinician. Recently, evidence has emerged that this patient population is at increased risk of development of life-threatening ventricular tachyarrhythmia and, pending prospective trials, we suggest that ICD therapy should be used in appropriately selected patients with perioperative ventricular arrhythmia.",
keywords = "Cardiac surgery ventricular tachyarrhythmia, Implantable cardioverter defibrillator",
author = "Islam Bolad and Martin, {David T.}",
year = "2005",
month = "7",
doi = "10.1016/j.eupc.2005.02.121",
language = "English (US)",
volume = "7",
pages = "317--318",
journal = "Europace",
issn = "1099-5129",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Have all the ICD primary prevention trials excluded an important group of patients?

AU - Bolad, Islam

AU - Martin, David T.

PY - 2005/7

Y1 - 2005/7

N2 - Primary prevention trials of implantable cardioverter defibrillator (ICD) therapy have generally excluded patients early after revascularization. Clinicians are commonly faced with patients who have ventricular dysfunction and nonsustained ventricular tachyarrhythmia developing shortly after revascularization. Since there are no evidence-based guidelines, management is currently at the discretion of the treating clinician. Recently, evidence has emerged that this patient population is at increased risk of development of life-threatening ventricular tachyarrhythmia and, pending prospective trials, we suggest that ICD therapy should be used in appropriately selected patients with perioperative ventricular arrhythmia.

AB - Primary prevention trials of implantable cardioverter defibrillator (ICD) therapy have generally excluded patients early after revascularization. Clinicians are commonly faced with patients who have ventricular dysfunction and nonsustained ventricular tachyarrhythmia developing shortly after revascularization. Since there are no evidence-based guidelines, management is currently at the discretion of the treating clinician. Recently, evidence has emerged that this patient population is at increased risk of development of life-threatening ventricular tachyarrhythmia and, pending prospective trials, we suggest that ICD therapy should be used in appropriately selected patients with perioperative ventricular arrhythmia.

KW - Cardiac surgery ventricular tachyarrhythmia

KW - Implantable cardioverter defibrillator

UR - http://www.scopus.com/inward/record.url?scp=20344366519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20344366519&partnerID=8YFLogxK

U2 - 10.1016/j.eupc.2005.02.121

DO - 10.1016/j.eupc.2005.02.121

M3 - Article

VL - 7

SP - 317

EP - 318

JO - Europace

JF - Europace

SN - 1099-5129

IS - 4

ER -